NCT04095299View on ClinicalTrials.gov

Standard Dose Versus High Dose of Radiotherapy in Rectal Preservation With Chemo-radiotherapy in Rectal Cancer Patients

PHASE2RecruitingINTERVENTIONAL
Enrollment

111

Participants

Timeline

Start Date

January 20, 2020

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2028

Conditions
Cancer of Rectum
Interventions
RADIATION

50.4 Gy to the tumor and elective volume

Standard radiotherapy

RADIATION

62 Gy to the clinical tumor volume and 50.4 Gy to the elective volume

Experimental radiotherapy

DRUG

Capecitabine 825 mg/m2 twice daily on weekdays

Standard chemotherapy

Trial Locations (5)

Unknown

RECRUITING

Aalborg University Hospital, Aalborg

RECRUITING

Copenhagen University Hospital, Righshospitalet and Bispebjerg Hospital, Copenhagen

NOT_YET_RECRUITING

Zealand University Hospital, Næstved, Næstved

NOT_YET_RECRUITING

Zealand University Hospital, Roskilde, Roskilde

RECRUITING

Department of Oncology, Vejle Hospital, Vejle

All Listed Sponsors
lead

Vejle Hospital

OTHER

NCT04095299 - Standard Dose Versus High Dose of Radiotherapy in Rectal Preservation With Chemo-radiotherapy in Rectal Cancer Patients | Biotech Hunter | Biotech Hunter